Effectiveness of Homoeopathic medicines in Autism
Phase 3
Completed
- Conditions
- Health Condition 1: null- Autism
- Registration Number
- CTRI/2016/04/006856
- Lead Sponsor
- Central Council for Research in Homoeopathy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 79
Inclusion Criteria
•Cases diagnosed as per ICD-10 criteria for Autism
•Age group 3-16 yrs. of age
•Both the sexes
•People from different socio economic background
•Parent or guardian willing to provide informed consent
•Cases of Autism under conventional medicines after a wash out period of 2 weeks
Exclusion Criteria
•Drug resistant epilepsy (in the last 3 months no attacks reported)
•Medical illness other than autism affecting the whole body, physical, neurological or psychiatric
•Severe cases of Autism in which conventional medicines are difficult to withdraw
•Patient with focal neurological diseases
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method More than 50% reduction in symptom score in comparison to baseline as per CARS, VSMS, ATEC, AHS and CGI Rating Scale at the end of treatment .Timepoint: 2 years
- Secondary Outcome Measures
Name Time Method improvement of symptoms on which prescription was basedTimepoint: 3 years;ï?§Improvement of symptoms, on which prescription was based. <br/ ><br>ï?§Improvement of symptoms other than, on which prescription was based. <br/ ><br>ï?§Improvement in their abilities to integrate into schools, develop meaningful peer relationships. <br/ ><br>â?¢Improvement in verbal and non-verbal communication. <br/ ><br>â?¢Improvement in socially acceptable and prosocial behavior. Reduction in odd behavioural symptom <br/ ><br>â?¢Improvement in quality of life <br/ ><br>Timepoint: 2 years